These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27228628)

  • 1. A New Way of Thinking about Systemic Sclerosis: The Opportunity for a Very Early Diagnosis.
    Guiducci S; Bellando-Randone S; Matucci-Cerinic M
    Isr Med Assoc J; 2016; 18(3-4):141-3. PubMed ID: 27228628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach.
    Bellando-Randone S; Matucci-Cerinic M
    Curr Rheumatol Rev; 2013; 9(4):245-8. PubMed ID: 26932288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very early diagnosis of systemic sclerosis.
    Bellando-Randone S; Guiducci S; Matucci-Cerinic M
    Pol Arch Med Wewn; 2012; 122 Suppl 1():18-23. PubMed ID: 23222375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of progression to systemic sclerosis: analysis of very early diagnosis of systemic sclerosis in a large single-centre cohort.
    Siqueira VS; Helbingen MFS; Medeiros-Ribeiro AC; Carriço da Silva H; Miossi R; Luppino-Assad AP; Sampaio-Barros PD
    Rheumatology (Oxford); 2022 Aug; 61(9):3686-3692. PubMed ID: 35020814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very Early Diagnosis of Systemic Sclerosis in Clinical Practice - Case Report and Review of the Literature.
    Marković I; Posavec AL; Morović-Vergles J; Mitrović J
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):251-255. PubMed ID: 36919392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria of systemic sclerosis.
    Hudson M; Fritzler MJ
    J Autoimmun; 2014; 48-49():38-41. PubMed ID: 24461384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.
    Lambova S; Hermann W; Muller-Ladner U
    Curr Rheumatol Rev; 2013; 9(4):254-60. PubMed ID: 26932290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon.
    Park JS; Park MC; Song JJ; Park YB; Lee SK; Lee SW
    Arthritis Res Ther; 2015 Mar; 17(1):77. PubMed ID: 25889905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
    Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE
    Ann Rheum Dis; 2009 Sep; 68(9):1377-80. PubMed ID: 19674983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early systemic sclerosis-opportunities for treatment.
    Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
    Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.
    Schneeberger D; Tyndall A; Kay J; Søndergaard KH; Carreira PE; Morgiel E; Deuschle K; Derk CT; Widuchowska M; Walker UA
    Rheumatology (Oxford); 2013 Mar; 52(3):560-7. PubMed ID: 23221323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.
    Ikawa Y; Hamaguchi Y; Mugii N; Matsushita T; Takehara K
    Mod Rheumatol; 2017 Jul; 27(4):614-617. PubMed ID: 27830961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic SR; Damjanov NS; Vujasinovic Stupar NZ; Baltic S; Babic DD
    Rheumatol Int; 2013 Dec; 33(12):2967-73. PubMed ID: 23934522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.